Journal
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Volume 18, Issue 1, Pages 44-46Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00002093-200401000-00009
Keywords
amyloid; immunoglobulin G; cytokine
Categories
Ask authors/readers for more resources
Recent preliminary data suggest that vaccination with Alzheimer AD might reduce senile plaque load and stabilize cognitive decline in human Alzheimer disease. To examine the mechanisms and consequences of anti-Abeta-antibody formation in a species more closely related to humans, rhesus monkeys (Macaca mulatta) were vaccinated with aggregated Abeta1-42. Immunized monkeys developed anti-Abeta titers exceeding 1: 1000, and their plasma Abeta levels were 5- to 10-fold higher than the plasma AD levels observed in monkeys vaccinated with aggregated amylin. These data support the use of nonhuman primates to model certain phenomena associated with vaccination of humans with aggregated Alzheimer AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available